1[1]Kim NW, Piatyszek MA, Prowse KR, et al. Specific associa tion of human telomerase activity with immortal cells and cancer. Science, 1994, 266(5193): 2011～2015
2[2]Kim NW. Clinical implications of telomerase in cancer. Eur J Cancer, 1997, 33(5):781～786
3[3]Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer, 1997, 33(5): 787～791
4[4]Yoshida K, Sugino T, Tahara H, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagno sis by detection of exfoliated cancer cells in urine. Cancer, 1997, 79(2):362～369
5[5]Yoshida K, Sugino T, Goodison S, et al. Detection of telom erase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer, 1997, 75(4):548～553
6[6]Kyo S, Takakura M, Ishilcowa H, et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res, 1997, 57(10): 1863～1867
7[7]Mu XC, Brien TP, Ross JS, et al. Telomerase activity in be nign and malignant cytologic fluids. Cancer, 1999,87(2):93～99
8[8]Toshima S, Arai T, Yasuda Y, et al. Cytological diagnostic and telomerase activity of cells in effusions of body cavities. Oncol Rep, 1999, 6(1):199～203
9[9]Yang CT, Lee MH, Lan RS, et al. Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol, 1998,16 (2):567～573
10[10]Tangkijvanich P, Tresukosol D, Sampatanukul P, et al. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites. Clin Cancer Res, 1999, 5(9): 2470～2475
7Queiroz c, Barral-Netto M, Bacchi CE. Characterizing subpopulations of neoplastic cells in serous effusions. The role of immunocytochemistry. Acta Cvtol 2001; 45:18-22
8Krishan A, Ganjei-Azar P, Jorda M, Hamelik RM, Reis IM, Nadji M. Detection of tumor cells in body cavity fluids by flow cytornetric and immunocytochemical analysis. Diagn Cytopathol 2006; 34:528-541
9汤钊猷.现代肿瘤学.第2版.上海:复旦大学出版社,2005:364
10Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Rodriguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004; 126:1757-1763
